Addus HomeCare (NASDAQ:ADUS) Price Target Cut to $136.00 by Analysts at Royal Bank of Canada

Addus HomeCare (NASDAQ:ADUS) had its price target decreased by Royal Bank of Canada from $141.00 to $136.00 in a report released on Wednesday, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock.

Other analysts have also issued research reports about the stock. KeyCorp initiated coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 target price for the company. Stephens reaffirmed an “overweight” rating and set a $138.00 price objective on shares of Addus HomeCare in a research report on Tuesday, August 6th. Oppenheimer increased their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. TD Cowen lifted their target price on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Finally, Macquarie reaffirmed an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a report on Monday. One analyst has rated the stock with a sell rating, eight have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $131.63.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock opened at $130.96 on Wednesday. The firm has a market cap of $2.37 billion, a PE ratio of 29.97, a price-to-earnings-growth ratio of 2.29 and a beta of 1.04. Addus HomeCare has a 1 year low of $81.51 and a 1 year high of $136.12. The firm’s 50-day simple moving average is $129.75 and its 200-day simple moving average is $120.92.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The company had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. During the same quarter last year, the business posted $1.03 EPS. Addus HomeCare’s quarterly revenue was up 7.1% compared to the same quarter last year. On average, equities analysts predict that Addus HomeCare will post 4.57 earnings per share for the current year.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares in the company, valued at approximately $429,165. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, Director Esteban Lopez sold 500 shares of the stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now directly owns 3,366 shares in the company, valued at $429,165. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 22,917 shares of company stock worth $3,050,082 in the last three months. 4.60% of the stock is owned by company insiders.

Institutional Trading of Addus HomeCare

Several institutional investors have recently modified their holdings of the company. UMB Bank n.a. raised its position in Addus HomeCare by 64.2% in the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after acquiring an additional 88 shares in the last quarter. Quest Partners LLC acquired a new position in shares of Addus HomeCare in the 2nd quarter worth approximately $31,000. EntryPoint Capital LLC bought a new stake in shares of Addus HomeCare in the 1st quarter worth approximately $44,000. Innealta Capital LLC acquired a new stake in Addus HomeCare during the second quarter valued at approximately $44,000. Finally, Farther Finance Advisors LLC boosted its holdings in Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after buying an additional 366 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.